Exploring how dried blood spot technology is transforming hepatitis B and C diagnosis in resource-limited settings through innovative seromarker detection.
Exploring the diagnostic challenges of antibody cross-reactivity in tropical diseases like malaria and filariasis, and their impact on HIV testing accuracy.
Exploring the pivotal 1989 clinical trial that tested dideoxycytidine (ddC) and measured its impact through p24 levels—a study whose legacy resonates in today's cutting-edge HIV diagnostics.